Test Strip Market Size
| Study Period | 2021 - 2029 |
| Market Size (2024) | USD 13.83 Billion |
| Market Size (2029) | USD 16.72 Billion |
| CAGR (2024 - 2029) | 3.87 % |
| Fastest Growing Market | North America |
| Largest Market | Asia-Pacific |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Test Strip Market Analysis
The Test Strip Market size is estimated at USD 13.83 billion in 2024, and is expected to reach USD 16.72 billion by 2029, growing at a CAGR of 3.87% during the forecast period (2024-2029).
Factors such as the increasing burden of diabetes and urinary tract infections worldwide, the rising preference for point-of-care (POC) testing, and increasing technological advancements in test strips across the world are predicted to fuel the market's growth.
The test strip market is expected to grow significantly over the projected period, owing to the increased prevalence of diabetes and urinary tract infections (UTIs) worldwide. For instance, according to the data updated by IDF Diabetes Atlas' 10th edition report, diabetes cases are predicted to rise to 643 million by 2030 and 783 million by 2045. Thus, the increasing burden of diabetes among the population worldwide is anticipated to boost the demand for blood glucose test strips, which are widely used to diagnose diabetes, thereby boosting the market.
Moreover, the rising prevalence of diabetes directly translates to a surging demand for blood glucose test strips. These strips are vital tools for individuals with diabetes to monitor their blood sugar levels effectively and manage their condition. For instance, according to a report published by the Diabetologia Journal in February 2024, the declining incidence of type 2 diabetes in Bavaria, Germany, in 2023, driven by effective screening and early diagnosis, necessitates increased monitoring and management, thereby propelling the growth of the test strip market.
Furthermore, according to the same source, with the prevalence of diabetes expected to rise by 54-77% by 2040 in Germany, the demand for blood glucose monitoring solutions may surge, underscoring the critical role of test strips in managing this chronic condition. These factors are expected to boost the market's growth in the upcoming years.
Additionally, the increasing rate of unwanted pregnancies is expected to boost the demand for pregnancy test strips. For instance, the data updated by the Guttmacher Institute and the World Health Organization in March 2023 stated that there was a staggering number of unintended pregnancies globally, and more than one in 10 women of all pregnancies were unintended. Such a high number of unexpected pregnancies is expected to bolster the demand for test trips, thereby boosting the market's growth.
Additionally, integrating test strips with mobile apps or telehealth platforms enables real-time data analysis and sharing with healthcare professionals, thereby improving diabetes management. For instance, according to a report published by the Endotext Journal in July 2023, mobile apps connected to blood glucose monitors are driving the growth of the blood glucose test strips landscape by enhancing real-time data collection and analysis, which facilitates timely and precise treatment adjustments. This integration streamlines diabetes management, leading to increased demand for test strips as part of comprehensive glucose monitoring solutions.
Thus, all the aforementioned factors are anticipated to drive the market's growth over the forecast period. However, reimbursement and the inaccuracy of test strips may limit the market during the forecast period.
Test Strip Market Trends
The Diabetes Segment is Anticipated to Witness Significant Growth Over the Forecast Period
For diabetic patients, diabetes test strips are a convenient way to check blood sugar levels, often known as glucose levels. This is especially crucial for the diabetic population. The strips read blood sugar levels using glucose meters. With an increase in the prevalence and incidence of diabetes globally, the number of diabetes tests is also increasing, which is expected to contribute to the segment's growth.
The number of diabetes cases is on the rise in both developing and established economies worldwide, contributing to the high demand for test strips. Another key growth-promoting aspect is the public's increased preference for point-of-care testing. For instance, according to the data updated by the Centers for Disease Control and Prevention (CDC), reported by World Diabetes Day pronouncements in November 2023, more than one-third of Americans are at risk for type 2 diabetes, and the need for tools to monitor blood sugar levels is poised to rise dramatically.
In addition, a study published by the British Diabetic Association from 2022 to 2023 highlighted that over 5.6 million people in the United Kingdom are living with diabetes, the highest number ever recorded. This represents a significant increase of 167,822 compared to the 2022. According to the QOF prevalence data, in England, over 7.5% of the population aged 17 and over, roughly 3.7 million people, have diabetes. Type 2 diabetes is the most prevalent form, affecting over 3.4 million people in England. However, type 1 diabetes also plays a role, with nearly 270,000 cases. This population is anticipated to drive the demand for the use of test strips for diabetes, ultimately boosting the market's growth in the region.
The escalating prevalence of obesity is expected to be a significant driver for the test strip market. As the number of people struggling with obesity increases, so too will the demand for effective treatment options. For instance, according to the World Obesity Federation, a report published by the World Obesity Atlas in March 2023 highlighted that a staggering rise in obesity is expected globally. Projections suggest that by 2035, over 4 billion people could be affected, a significant increase from over 2.6 billion in 2020. This translates to a leap from 38% to over 50% of the world’s population being overweight or obese. As the number of diabetes diagnoses increases due to obesity, the demand for tools like test strips to manage the condition also rises, thereby driving the test strip market.
Technological advancements are also anticipated to boost the segment's growth. For instance, in March 2024, Roche launched its latest innovation, Accu-Chek SmartGuide. This new device marks Roche's entry into the continuous glucose monitoring (CGM) market. It utilizes AI to predict future glucose trends, empowering users to make informed decisions about diet and medication.
Thus, these increasing cases of diabetes and developments by key market players to bring technologically advanced products into the market are expected to boost the segment's growth.
North America is Anticipated to Hold a Significant Market Share Over the Forecast Period
North America holds a major share of the market studied and is expected to continue to do so over the forecast period. Some of the factors driving the market growth in North America include increasing cases of diabetes and efforts by the national governments to manage the disease at a larger level, along with the rising adoption of test strips and the presence of key market players.
The high prevalence of urinary tract infections (UTIs) in the United States is fueling the demand for test strips as a convenient and effective tool for diagnosis, contributing to the growth of the test strip market. For instance, according to the study published by the Eastern Virginia Medical School in November 2023, nearly 40% of women will experience UTIs at some point in their lives, and there is a constant need for fast and reliable diagnosis. Test strips are a user-friendly and cost-effective way for healthcare providers to diagnose UTIs quickly. They allow for easy detection of factors like white blood cells and nitrites in urine, which can indicate infection. This population is anticipated to drive the demand for test strips for UTIs, ultimately boosting the market's growth in the region.
Additionally, the introduction of innovative technologies in blood glucose monitoring is significantly transforming the US test strip market, making diabetes screening more accessible and cost-effective. For instance, in March 2023, GlucoScreen, developed by researchers at the University of Washington in Seattle, represents a breakthrough in glucose testing technology. This modified version of a commercially available test strip leverages the capacitive touch-sensing capabilities of smartphones to measure blood glucose levels without needing a separate reader. This is further expected to create demand for test strips, driving the market's growth.
Furthermore, the substantial number of Canadians with diabetes and prediabetes creates a significant demand for test strips as a crucial tool for blood sugar monitoring and diabetes management. For instance, in January 2023, Empower Clinics Inc. announced that its subsidiary, MediSure Canada, received approval for its MediSure Empower test strips to be included in the formularies of four key government jurisdictions, including the provinces of Alberta and Quebec, Veterans Affairs Canada, and Non-insured Health Benefits for First Nations and Inuit. These approvals underscore the importance of MediSure's diabetes testing solutions in meeting the needs of a diverse patient population across Canada. Therefore, such approvals are expected to fuel the growth of the test strip market in Canada.
Moreover, product launches by key market players are expected to further boost the market growth. For instance, in August 2023, Clearblue, a brand in home pregnancy and fertility testing, made a strategic move into the menopause management industry with the launch of the Clearblue Menopause Stage Indicator, which is the first at-home test to combine follicle-stimulating hormone (FSH) measurements with age and cycle data to provide a personalized indication of menopause stage. Therefore, the manufacturers are focusing on launching innovative products that may increase the adoption of test strips during the forecast period.
Thus, owing to the rising burden of urinary tract infections and continuous innovative product launches, the market studied is expected to witness growth over the forecast period in North America.
Test Strip Industry Overview
The test strip market is competitive and rising rapidly. It is fragmented owing to the presence of several market players. The key players are widening their share by improving demand in developing regions. The key strategies in the competitive landscape are market expansion, acquisitions, and partnerships. The major players in the market include Abbott, ACON Laboratories Inc., Ascensia Diabetes Care Holdings AG, ARKRAY Inc., B. Braun SE, and LifeScan IP Holdings LLC.
Test Strip Market Leaders
-
B. Braun SE
-
ARKRAY, Inc.
-
Ascensia Diabetes Care Holdings AG
-
ACON Laboratories, Inc.
-
Abbott
*Disclaimer: Major Players sorted in no particular order
Test Strip Market News
- April 2024: OVUM launched the nation's first fully recyclable early-detection pregnancy tests. Its products are sold in Sainsbury's stores across the United Kingdom. OVUM's B Corp certification highlights its commitment to environmental and social responsibility. This focus on sustainability, alongside its innovative products, is expected to resonate with eco-conscious consumers.
- May 2023: Roche Diabetes Care India (RDC India) expanded the local manufacturing of its Accu-Chek Active blood glucose monitor. RDC India produces its Accu-Chek Active blood glucose monitoring device within India. This shift from previous manufacturing locations signifies a strategic move.
Test Strip Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Diabetes and Urinary Tract Infection Across The Globe
4.2.2 Rising Preference for Point of Care Testing
4.2.3 Increasing Technological Advancements in Test Strips
4.3 Market Restraints
4.3.1 Dearth of Reimbursement Policies
4.3.2 Lack of Accuracy in Test Results
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD )
5.1 By Product
5.1.1 Blood Test Strips
5.1.2 Urine Test Strips
5.2 By Application
5.2.1 Diabetes
5.2.2 Pregnancy
5.2.3 Urinary Tract Infection
5.2.4 Other Applications
5.3 By End User
5.3.1 Hospitals
5.3.2 Home Care
5.3.3 Diagnostic Laboratories
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott
6.1.2 ACON Laboratories, Inc.
6.1.3 Ascensia Diabetes Care Holdings AG
6.1.4 ARKRAY Inc.
6.1.5 B. Braun SE
6.1.6 LifeScan IP Holdings LLC
6.1.7 F. Hoffmann-La Roche Ltd
6.1.8 Siemens Healthineers AG
6.1.9 Tiadoc Technology Corporation
6.1.10 Teco Diagnostics
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Test Strip Industry Segmentation
As per the scope of the report, a test strip is a key component of blood glucose testing and urinalysis. It is used to monitor or control a diabetic patient's blood glucose level. It allows people who are pre-diabetic or diabetic to monitor their blood glucose levels regularly without going to a clinic or a diagnostic laboratory.
The test strip market is segmented by product (blood test strips and urine test strips), application (diabetes, pregnancy, urinary tract infection, and other applications), end user (hospitals, home care, and diagnostic laboratories), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers market sizes and forecasts in terms of value (USD) for the above-mentioned segments.
| By Product | |
| Blood Test Strips | |
| Urine Test Strips |
| By Application | |
| Diabetes | |
| Pregnancy | |
| Urinary Tract Infection | |
| Other Applications |
| By End User | |
| Hospitals | |
| Home Care | |
| Diagnostic Laboratories |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Test Strip Market Research FAQs
How big is the Test Strip Market?
The Test Strip Market size is expected to reach USD 13.83 billion in 2024 and grow at a CAGR of 3.87% to reach USD 16.72 billion by 2029.
What is the current Test Strip Market size?
In 2024, the Test Strip Market size is expected to reach USD 13.83 billion.
Who are the key players in Test Strip Market?
B. Braun SE, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG, ACON Laboratories, Inc. and Abbott are the major companies operating in the Test Strip Market.
Which is the fastest growing region in Test Strip Market?
North America is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Test Strip Market?
In 2024, the Asia-Pacific accounts for the largest market share in Test Strip Market.
What years does this Test Strip Market cover, and what was the market size in 2023?
In 2023, the Test Strip Market size was estimated at USD 13.29 billion. The report covers the Test Strip Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Test Strip Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Test Strip Industry Report
Statistics for the 2023 Test Strip market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Test Strip analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
